Head of FDA Stephen Hahn, Commissioner Oct. 2020
Post# of 148168
Oct. 2020
“Now, you and I, I think we both would agree as doctors, if there are data available on any therapeutic that look like it could save a life during a pandemic, and it is safe and it fulfills the criteria of "may be effective," and the risk-benefit ratio is in the right direction, then we should go forward with it."